Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Sensitization of cells to x-ray by 5-chloro-2'-deoxycytidine: studies on the metabolism and incorporation in DNA of a novel radiosensitizer

Thesis/Dissertation ·
OSTI ID:5885912
Rapid catabolism and generalized toxicity have limited the use of 5-halogenated deoxyuridine analogs as tumor radiosensitizers. This problem was approached by utilizing a deoxycytidine analog, 5-chloro-2'-deoxycytidine (CldC) coadministered with tetrahydrouridine (H/sub 4/U), an inhibitor of its deamination. Enzyme kinetic data and studies in various cell lines indicate that CldC + H/sub 4/U may be metabolized as follows: CldC ..-->.. CldCMP ..-->.. CldUMP ..-->.. ..-->.. CldUTP ..-->.. DNA ((1) deoxycytidine kinase; (2) deoxycytidylate deaminase dCMPD; (3) thymidylate kinase; and (4) DNA polymerase). All of these enzymes are elevated in human and mouse malignant tumors above that of normal tissues; especially dCMPD, which is elevated 20- to 80-fold. In tumors high in cytidine deaminase (CD), the following pathway is also likely involved: CldC ..-->.. CldU ..-->.. CldUMP ..-->.. ..-->.. CldUTP ..-->.. DNA ((1) Cd and (2) thymidine kinase). It is not known whether one of these two pathways (Cd ..-->.. TK or dCK ..-->.. dCMPD) is preferred in tumors. CldC + H/sub 4/U sensitized cells (HEp-2, S-180 and RIF-1) to X-ray and was incorporated in DNA as CldU at a substitution level of 20 to 30%. CHO cells, which intrinsically lack both CD and dCMPD were sensitized by CldU but displayed only marginal X-ray sensitization with CldC + H/sub 4/U. Thus, both pathways of conversion (dCK ..-->.. dCMPD; CD ..-->.. TK) of CldC to CldUMP cannot be blocked.
Research Organization:
Miami Univ., Coral Gables, FL (USA)
OSTI ID:
5885912
Country of Publication:
United States
Language:
English